Indefinite Delivery Contract 75N98026D00082

The National Institute on Aging awarded a single-award indefinite-delivery contract to Progenics Pharmaceuticals Inc. with a ceiling of $1,211,250 on September 22, 2026, to supply NeuraSeq amyloid radiotracers for the Baltimore Longitudinal Study of Aging (BLSA). The contract is not set-aside and carries a completion date of September 21, 2031.

Place of performance is the United States. The originating solicitation, issued as a non-competitive, sole-source request for quotation under FAR Part 13 and FAR Part 12, called for the supply of 62 amyloid radiotracers with scientific continuity as the justification for sole-source procurement. The solicitation (75N98026Q01057) was posted August 26, 2026, with a response deadline of August 31, 2026. NAICS code 325414 (Biological Product Manufacturing) and PSC code 6505 (Drugs and Biologicals) apply to the procurement.

Progenics Pharmaceuticals Inc. is a division of Lantheus Medical Imaging, Inc. and operates from North Billerica, Massachusetts (primary manufacturing and distribution) and Bedford, Massachusetts. The contract carries firm fixed-price terms.